$2.5T
Total marketcap
$59.12B
Total volume
BTC 50.20%     ETH 16.03%
Dominance

Envista NVST Stock

19.18 USD {{ price }} -4.529616% {{change_pct}}%
Exchange
NYSE
Market Cap
3.3B USD
LOW - HIGH [24H]
19.08 - 19.91 USD
VOLUME [24H]
1.6M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.6 USD

Envista Price Chart

Envista NVST Financial and Trading Overview

Envista stock price 19.18 USD
Previous Close 31.53 USD
Open 31.59 USD
Bid 30.64 USD x 800
Ask 35.97 USD x 1000
Day's Range 31.34 - 32.69 USD
52 Week Range 31.2 - 43.29 USD
Volume 2.61M USD
Avg. Volume 2.06M USD
Market Cap 5.34B USD
Beta (5Y Monthly) 1.430551
PE Ratio (TTM) 26.528456
EPS (TTM) -0.6 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 44.5 USD

NVST Valuation Measures

Enterprise Value 6.29B USD
Trailing P/E 26.528456
Forward P/E 15.319248
PEG Ratio (5 yr expected) 1.61
Price/Sales (ttm) 2.0825748
Price/Book (mrq) 1.2483263
Enterprise Value/Revenue 2.453
Enterprise Value/EBITDA 12.872

Trading Information

Envista Stock Price History

Beta (5Y Monthly) 1.430551
52-Week Change -8.31%
S&P500 52-Week Change 20.43%
52 Week High 43.29 USD
52 Week Low 31.2 USD
50-Day Moving Average 35.43 USD
200-Day Moving Average 35.87 USD

NVST Share Statistics

Avg. Volume (3 month) 2.06M USD
Avg. Daily Volume (10-Days) 2.17M USD
Shares Outstanding 163.7M
Float 163.16M
Short Ratio 4.74
% Held by Insiders 0.33%
% Held by Institutions 115.61%
Shares Short 11.36M
Short % of Float 7.83%
Short % of Shares Outstanding 6.94%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 8.26%
Operating Margin (ttm) 13.48%
Gross Margin 57.83%
EBITDA Margin 19.05%

Management Effectiveness

Return on Assets (ttm) 3.28%
Return on Equity (ttm) 5.08%

Income Statement

Revenue (ttm) 2.56B USD
Revenue Per Share (ttm) 15.71 USD
Quarterly Revenue Growth (yoy) -0.70%
Gross Profit (ttm) 1.49B USD
EBITDA 488.7M USD
Net Income Avi to Common (ttm) 211.4M USD
Diluted EPS (ttm) 1.23
Quarterly Earnings Growth (yoy) -41.50%

Balance Sheet

Total Cash (mrq) 585.2M USD
Total Cash Per Share (mrq) 3.58 USD
Total Debt (mrq) 1.53B USD
Total Debt/Equity (mrq) 35.86 USD
Current Ratio (mrq) 1.23
Book Value Per Share (mrq) 26.139

Cash Flow Statement

Operating Cash Flow (ttm) 182.3M USD
Levered Free Cash Flow (ttm) 209.28M USD

Profile of Envista

Country United States
State CA
City Brea
Address Building E
ZIP 92821-6208
Phone 714 817 7000
Website https://envistaco.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 12700

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Q&A For Envista Stock

What is a current NVST stock price?

Envista NVST stock price today per share is 19.18 USD.

How to purchase Envista stock?

You can buy NVST shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Envista?

The stock symbol or ticker of Envista is NVST.

Which industry does the Envista company belong to?

The Envista industry is Medical Instruments & Supplies.

How many shares does Envista have in circulation?

The max supply of Envista shares is 171.86M.

What is Envista Price to Earnings Ratio (PE Ratio)?

Envista PE Ratio is now.

What was Envista earnings per share over the trailing 12 months (TTM)?

Envista EPS is -0.6 USD over the trailing 12 months.

Which sector does the Envista company belong to?

The Envista sector is Healthcare.

Envista NVST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NYSE COMPOSITE (DJ) NYA 17639.04 USD
-1.54
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD